These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 17164713)

  • 21. Survival benefit after liver transplantation: a single European center experience.
    Ravaioli M; Grazi GL; Dazzi A; Bertuzzo V; Ercolani G; Cescon M; Cucchetti A; Masetti M; Ramacciato G; Pinna AD
    Transplantation; 2009 Sep; 88(6):826-34. PubMed ID: 19920783
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of short-term survival after liver transplant by the Model for End-Stage Liver Disease.
    Buenadicha AL; Martín LG; Martín EE; Pajares Ad; Pérez AM; Seral CC; Marugán RB
    Transplant Proc; 2005 Nov; 37(9):3881-3. PubMed ID: 16386571
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Model for end-stage liver disease score-based allocation of donors for liver transplantation: a spanish multicenter experience.
    de la Mata M; Cuende N; Huet J; Bernardos A; Ferrón JA; Santoyo J; Pascasio JM; Rodrigo J; Solórzano G; Martín-Vivaldi R; Alonso M
    Transplantation; 2006 Dec; 82(11):1429-35. PubMed ID: 17164713
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The value of MELD in the allocation of priority for liver transplantation candidates].
    Colmenero J; Castro-Narro G; Navasa M
    Gastroenterol Hepatol; 2010 Apr; 33(4):330-6. PubMed ID: 19631411
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Model for end-stage liver disease exceptions in the context of the French model for end-stage liver disease score-based liver allocation system.
    Francoz C; Belghiti J; Castaing D; Chazouillères O; Duclos-Vallée JC; Duvoux C; Lerut J; Le Treut YP; Moreau R; Mandot A; Pageaux G; Samuel D; Thabut D; Valla D; Durand F
    Liver Transpl; 2011 Oct; 17(10):1137-51. PubMed ID: 21695771
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Allocation policy for hepatocellular carcinoma in the MELD era: room for improvement?
    Roayaie K; Feng S
    Liver Transpl; 2007 Nov; 13(11 Suppl 2):S36-43. PubMed ID: 17969067
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MELD-based liver allocation: who is underserved?
    Biggins SW; Bambha K
    Semin Liver Dis; 2006 Aug; 26(3):211-20. PubMed ID: 16850370
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Model for end-stage liver disease (MELD) for liver allocation: a 5-year score card.
    Freeman RB
    Hepatology; 2008 Mar; 47(3):1052-7. PubMed ID: 18161047
    [No Abstract]   [Full Text] [Related]  

  • 29. Patient selection in an era of donor liver shortage: current US policy.
    Wiesner RH
    Nat Clin Pract Gastroenterol Hepatol; 2005 Jan; 2(1):24-30. PubMed ID: 16265097
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Liver transplantation: an update.
    Said A; Lucey MR
    Curr Opin Gastroenterol; 2006 May; 22(3):272-8. PubMed ID: 16550042
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Allocation priority in non-urgent liver transplantation: An overview of proposed scoring systems.
    Gitto S; Lorenzini S; Biselli M; Conti F; Andreone P; Bernardi M
    Dig Liver Dis; 2009 Oct; 41(10):700-6. PubMed ID: 19502118
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Prognostic indices in liver cirrhosis and transplant assessment].
    Bak-Nafalska K; Piotrowska A; Wójcicki M; Milkiewicz P
    Pol Merkur Lekarski; 2010 May; 28(167):410-5. PubMed ID: 20568409
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A quarter century of liver transplantation at UCLA.
    Duffy JP; Farmer DG; Busuttil RW
    Clin Transpl; 2007; ():165-70. PubMed ID: 18637468
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patient selection criteria for liver transplantation.
    Yu AS; Keeffe EB
    Minerva Chir; 2003 Oct; 58(5):635-48. PubMed ID: 14603144
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selecting an optimal prognostic system for liver cirrhosis: the model for end-stage liver disease and beyond.
    Huo TI; Lee SD; Lin HC
    Liver Int; 2008 May; 28(5):606-13. PubMed ID: 18433390
    [TBL] [Abstract][Full Text] [Related]  

  • 36. When is a patient too well and when is a patient too sick for a liver transplant?
    Merion RM
    Liver Transpl; 2004 Oct; 10(10 Suppl 2):S69-73. PubMed ID: 15382215
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The model for end-stage liver disease comes of age.
    Freeman RB
    Clin Liver Dis; 2007 May; 11(2):249-63. PubMed ID: 17606205
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Model for End Stage Liver Disease and hepatocellular carcinoma: a moving target.
    Washburn K
    Transplant Rev (Orlando); 2010 Jan; 24(1):11-7. PubMed ID: 19942101
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liver transplantation: an update 2007.
    Said A; Einstein M; Lucey MR
    Curr Opin Gastroenterol; 2007 May; 23(3):292-8. PubMed ID: 17414845
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Split liver transplantation: a reliable approach to expand donor pool.
    Yan JQ; Becker T; Peng CH; Li HW; Klempnauer J
    Hepatobiliary Pancreat Dis Int; 2005 Aug; 4(3):339-44. PubMed ID: 16109512
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.